439
Views
10
CrossRef citations to date
0
Altmetric
Reviews

Phase I/II RAF kinase inhibitors in cancer therapy

, , &
Pages 739-749 | Published online: 06 May 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Juan Martin-Liberal & James Larkin. (2014) New RAF kinase inhibitors in cancer therapy. Expert Opinion on Pharmacotherapy 15:9, pages 1235-1245.
Read now
Tomi K Sawyer, Joe C Wu, Jonathon R Sawyer & Jessie M English. (2013) Protein kinase inhibitors: breakthrough medicines and the next generation. Expert Opinion on Investigational Drugs 22:6, pages 675-678.
Read now

Articles from other publishers (8)

Jingtong Zhao & Zhijun Luo. (2022) Discovery of Raf Family Is a Milestone in Deciphering the Ras-Mediated Intracellular Signaling Pathway. International Journal of Molecular Sciences 23:9, pages 5158.
Crossref
Galia Maik-Rachline, Izel Cohen & Rony Seger. 2018. Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways. Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways 89 116 .
Yingjun Li, Huimin Cheng, Zhang Zhang, Xiaoxi Zhuang, Jinfeng Luo, Huoyou Long, Yang Zhou, Yong Xu, Rana Taghipouran, Dan Li, Adam Patterson, Jeff Smaill, Zhengchao Tu, Donghai Wu, Xiaomei Ren & Ke Ding. (2015) N -(3-Ethynyl-2,4-difluorophenyl)sulfonamide Derivatives as Selective Raf Inhibitors . ACS Medicinal Chemistry Letters 6:5, pages 543-547.
Crossref
E. Gabriela Chiorean, Andrew Coveler, Jon Grim & William M. Grady. 2015. Intestinal Tumorigenesis. Intestinal Tumorigenesis 391 440 .
KI HWAN KWEON, CHO ROK LEE, SOO JUNG JUNG, EUN JEONG BAN, SANG-WOOK KANG, JONG JU JEONG, KEE-HYUN NAM, YOUNG SUK JO, JANDEE LEE & WOONG YOUN CHUNG. (2014) Sirt1 induction confers resistance to etoposide-induced genotoxic apoptosis in thyroid cancers. International Journal of Oncology 45:5, pages 2065-2075.
Crossref
David Romano, David Matallanas, Dennie T. FrederickKeith T. FlahertyWalter Kolch. (2014) One Hippo and many masters: differential regulation of the Hippo pathway in cancer. Biochemical Society Transactions 42:4, pages 816-821.
Crossref
Botond Cseh, Eszter Doma & Manuela Baccarini. (2014) “RAF” neighborhood: Protein-protein interaction in the Raf/Mek/Erk pathway. FEBS Letters 588:15, pages 2398-2406.
Crossref
Tetyana Tegnebratt, Li Lu, Lucy Lee, Valerie Meresse, Jean Tessier, Nobuya Ishii, Naoki Harada, Pavel Pisa & Sharon Stone-Elander. (2013) [18 F]FDG-PET imaging is an early non-invasive pharmacodynamic biomarker for a first-in-class dual MEK/Raf inhibitor, RO5126766 (CH5126766), in preclinical xenograft models. EJNMMI Research 3:1, pages 67.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.